„Ozempic“ maker „Novo Nordisk“ changes its name
Danish pharmaceutical giant “Novo Nordisk”, producer of weight loss drugs “Ozempic” and “Wegovy”, announced on Monday that it is changing its name to simply “Novo” and…
Farmacijos pramonė
Read Full News
Poor clinical trial results for the drug have lowered Novartis’ stock value
This was reported a few days after the company announced poor and long-awaited Phase III clinical trial results for a heart disease drug, which were also worse than expected. Read more The district court will announce the decision in the case of Irma Gajauskaitė regarding riots and incitement on October 22 Novartis shares in Zurich…
Does the pharmaceutical industry really spend 19 times more on advertising than on research?
A claim is spreading on social networks that the pharmaceutical industry spends 19 times more on advertising than on scientific research. The impressive-sounding figure is not fabricated –…
After clinical trial failure, Pfizer reports losses
US pharmaceutical giant Pfizer reported second-quarter losses on Tuesday due to write-downs from unfavorable clinical results, despite overall…
„Bayer“ profit increased due to successful operations and lower legal expenses
German agrochemical giant Bayer announced on Tuesday that it again made a profit in the second quarter. This was influenced by successful agricultural business operations and lower legal expenses…
Spauda: „AstraZeneca“ ir „Bristol Myers Squibb“ svarsto apie 400 mlrd. JAV dolerių vertės
Didžiosios Britanijos farmacijos milžinė „AstraZeneca“ derasi su JAV konkurente „Bristol Myers Squibb“ (BMS) dėl beveik 400 mlrd. JAV dolerių vertės susijungimo, skelbia finansų…
Pharmaceutical giant AstraZeneca’s profit grew: it became clear what caused this jump
British pharmaceutical giant AstraZeneca announced on Monday that strong growth in cancer drug sales boosted its net profit in the second quarter of this year.
Pharmaceutical giants clashed over obesity drug advertising
Danish pharmaceutical giant Novo Nordisk announced on Tuesday that it had sued its main US competitor Eli Lilly over “false and fundamentally misleading” advertising…
New drugs increased Novartis sales in the second quarter
Swiss pharmaceutical giant Novartis announced on Tuesday that the group’s sales in the second quarter of this year exceeded expectations, driven by various new products.